ENVERIC BIOSCIENCES, INC. Other Current Liabilities
ENVERIC BIOSCIENCES, INC. (ENVB) had Other Current Liabilities of $99.88 thousand as of 2025-12-31, per its 10-K filed 2026-03-27.
Financial Statements › Balance Sheet › Liabilities, Current
us-gaap:OtherLiabilitiesCurrent · last filed 2026-03-27
- 2025-12-31: Other Liabilities, Current $99.88K.
- 2024-12-31: Other Liabilities, Current $232.89K.
- 2024-09-30: Other Liabilities, Current $4.94K.
- 2024-06-30: Other Liabilities, Current $4.44K.
| Period end | Other Liabilities, Current | Other Liabilities, Current as first filed |
|---|---|---|
| 2025-12-31 | $99.88K 10-K · filed 2026-03-27 | |
| 2024-12-31 | $232.89K 10-K · filed 2026-03-27 | |
| 2024-09-30 | $4.94K 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $4.44K 10-Q · filed 2024-08-12 | |
| 2024-03-31 | $12.21K 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $23.61K 10-Q · filed 2024-11-14 | |
| 2023-09-30 | $1.25M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $1.81M 10-Q · filed 2023-08-11 | |
| 2023-03-31 | $731.50K 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $851.01K 10-K · filed 2024-03-26 | |
| 2019-12-31 | $235.70K 10-K/A · filed 2020-08-12 | |
| 2018-12-31 | $283.37K 10-K/A · filed 2020-08-12 | |
| 2017-12-31 | $387.51K 10-K · filed 2019-03-26 | |
| 2016-12-31 | $567.42K 10-K · filed 2018-04-02 | $2.17M 10-K/A · filed 2017-04-04 |
| 2015-12-31 | $1.09M 10-K/A · filed 2017-04-04 | |
| 2015-09-30 | $1.82M 10-Q · filed 2015-11-23 | |
| 2015-06-30 | $442.52K 10-Q · filed 2015-08-18 | |
| 2015-03-31 | $566.01K 10-KT · filed 2016-03-15 | $146.79K 10-Q · filed 2015-08-17 |
| 2014-03-31 | $213.56K 10-KT · filed 2016-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |